INNT
TOTAL INVALIDATION PROCESSED BY THE IB
05/03/2026
Voltar para busca
Dado oficial do USPTO
OBEONE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
06/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10
Data de depósito
29/07/2016
Data de registro
19/06/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/01/2025
Última transação
06/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
34
Localização do titular
F-92284 Suresnes Cedex, FR
Examinador
TRATOS, MARK STEVEN
Unidade examinadora
M40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
BIOFARMA
Representantes
LISA GATES BAKER & MCKENZIE LLP
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of osteoporosis; sanitary products for medical purposessanitary towelssanitary napkinssanitary sterilizing preparations; implants for pharmaceutical useimplants comprising living tissuebiological implants in the nature of vital processed human or animal connective tissuemedical implants in the nature of implantable scaffolds comprising living tissue for maintaining tissue contour; implantable medicines for the prevention and treatment of diabetescardiovascular diseasesdiseases of the central nervous systemmetabolic disorderscancer; dietetic food substances adapted for medical use; food for babies; dietary supplementsenzyme food supplementsvitamin and mineral food supplementsherbal food supplements and trace element food supplements and dietetic food adapted for medical usepasta and crackersbarspowdered milkpollenamino acids and beverages; medical plasters used as material for dressings for medical purposes; materials used as wound dressing; medicated compresses for use in application of implants; teeth filling material; dental impression materials; disinfectants; preparations for destroying noxious animals; fungicidesherbicides; all the aforementioned goods for diabeticoncological and osteoporotic fields excluding veterinary products
Classe 10
Medical apparatus and instruments for treating diabetesmedical apparatus and instruments for treating cancermedical apparatus and instruments for treating osteoporosis; applicators for medicinespatches sold without medication; medical implants sold without medication made of artificial material for delivering medicine; artificial surgical implantssurgical implants comprising artificial material; applicators for pharmaceutical preparationssubcutaneous applicators sold without medication for administering medicine; pumps for medical use for administering pharmaceutical products contained in receptacles; infusion pumps for administering medicines for medical purposesinjection devices for pharmaceutical products; pharmaceutical implants in the nature of drug delivery systems; holders for medical useholders specially adapted for placement of medical and surgical applicators; surgical apparatus and instruments; cases fitted for medical instruments; suture materials; scalpels; knives for surgical purposes; surgical knives; scissors for surgery; knives for surgical use; cases fitted for use by doctors; containers especially made for medical waste; containers for applying medicinesmedical fluid injectors and infusers; all the aforementioned goods for diabeticoncological and osteoporotic fields excluding apparatus and instruments for the veterinary field
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
14/02/2026
INPC
INVALIDATION PROCESSED
14/02/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/09/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
03/09/2025
C71T
CANCELLED SECTION 71
03/01/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
19/06/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/10/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
26/09/2018
FIMP
FINAL DISPOSITION PROCESSED
26/09/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
19/09/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
19/06/2018
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
25/05/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/05/2018
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/05/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/04/2018
PUBO
PUBLISHED FOR OPPOSITION
03/04/2018
GPNX
NOTIFICATION PROCESSED BY IB
30/03/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
14/03/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/03/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
14/03/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/03/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
23/01/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
23/01/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
23/01/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
23/01/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/12/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/12/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
21/12/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
16/08/2017
GNFR
FINAL REFUSAL E-MAILED
16/08/2017
CNFR
FINAL REFUSAL WRITTEN
16/08/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/07/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/07/2017
ALIE
ASSIGNED TO LIE
29/07/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/06/2017
RFNT
REFUSAL PROCESSED BY IB
12/01/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
28/12/2016
RFRR
REFUSAL PROCESSED BY MPU
28/12/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
23/12/2016
CNRT
NON-FINAL ACTION WRITTEN
22/12/2016
MAFR
APPLICATION FILING RECEIPT MAILED
20/12/2016
DOCK
ASSIGNED TO EXAMINER
15/12/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/12/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/12/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace OBEONE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.